Forbes contributors publish independent expert analyses and insights. Attracting high-paying clients by marketing with a book and a speech. What lies ahead for marketing in 2023? I polled several ...

The Lenovo ThinkBook 16 G7 IML offers solid performance and built-in connectivity, offering a sleek and professional design with impressive display quality. Minor drawbacks include its weight and ...

In 2023, Transparency International worked as a united, global force for change. We have one vision: a world in which government, business, civil society and the daily lives of people are free of ...

More than a million abortions were provided in the U.S. in 2023. That's a major finding from a report published Tuesday by the Guttmacher Institute, a research organization that supports access to ...

The season is over. A champion has been crowned. All that's left is to deliver a final, comprehensive ranking of every quarterback who started a game in 2023, judging them by the entire regular season ...

In December, Euromonitor International released its annual list of the Top 100 City Destinations in the world for 2023. The report compared cities using 55 metrics across six categories, including ...

The Corruption Perceptions Index (CPI) scores 180 countries and territories by their perceived levels of public sector corruption, according to experts and business people. The CPI uses a scale from 0 ...

'Succession,' 'The Bear' and 'Beef' won the top awards for best drama series, best comedy series and best limited series, respectively. By Kimberly Nordyke Managing Editor, Digital Last Week Tonight ...

The U.S. economy added more than 2.6 million jobs for the third consecutive year—a feat that hasn't been accomplished since the most recent soft landing in the 1990s. While the number of jobs gained ...

During the fourth quarter of 2023, Tesla achieved new quarterly records for global electric vehicle production and sales, which contributed to the best year ever in terms of volume. However, there are ...

The FDA’s Center for Drug Evaluation and Research (CDER) approved 55 new drugs in 2023, as the small molecule and biologic pharmacopoeia continues to grow. This cohort is nearly 50% bigger than the ...

Well, that was a surprise. From the economy avoiding a recession to the massive stock market rally, 2023 defied expectations. Heading into the year, investors expected more difficulty for the stock ...